Skip to content
Search

Latest Stories

Obesity increases risk of cancer in youngsters: study

Youngsters who are obese have a higher risk of getting cancer, a new study says, adding that young adults who have body mass indexes of more than 30 are at risk of getting 13 different types of cancers.

"Young people with body mass indexes over 30 are more likely to experience aggressive malignancies," said the lead author of the study Nathan A. Berger, Professor at the Case Western Reserve University.


Even after losing weight, can risk remains. "If you are obese, you are at a higher risk of cancer. If you lose weight, it improves the prognosis and may lower your risk, but it never goes away completely," says Berger. Obesity causes changes to a person’s DNA that can increase cancer risk and remain long even after a person loses weight.

Berger's review shows that over activates the immune system to produce harmful byproducts like peroxide and oxygen radicals that mutate DNA. It can also alter a person’s metabolism, which causes hormone imbalances that help cancer cells grow.

Obese people with acid reflux risk getting esophageal cancer due to damages in their swallowing tubes. "Even if one pathway is successfully blocked, obesity-induced cancer takes another path," Berger says.

Adults with a history of obesity are twice as likely to develop multiple myeloma, Berger says, adding that it can also shorten cancer timelines by shrinking the period between benign and malignant cancer progression.

This may be one of the reasons for increase in cancer rates among young adults.

What can be done to prevent this? Early cancer screening tailored to young people and a detailed information of a person’s weight history should be maintained. But the most “effective way to curtail development of this problem is to prevent the expansion of the obesity pandemic in both children and adults," says Berger. If this is not done then more than 110 million children and adolescents with obesity worldwide are at risk of developing obesity-related cancers.

More For You

Camellia Panjabi's cookbook elevates
vegetables from sides to stars

Camellia Panjabi (Photo: Ursula Sierek)

Camellia Panjabi's cookbook elevates vegetables from sides to stars

RESTAURATEUR and writer Camellia Panjabi puts the spotlight on vegetables in her new book, as she said they were never given the status of a “hero” in the way fish, chicken or prawns are.

Panjabi’s Vegetables: The Indian Way features more than 120 recipes, with notes on nutrition, Ayurvedic insights and cooking methods that support digestion.

Keep ReadingShow less
Spotting the signs of dementia

Priya Mulji with her father

Spotting the signs of dementia

How noticing the changes in my father taught me the importance of early action, patience, and love

I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.

Keep ReadingShow less
HH Guruji performed the Dhwaja Ritual at Ambaji Temple

HH Guruji performed the Dhwaja Ritual at Ambaji Temple

Mahesh Liloriya

The holy town of Ambaji witnessed a spiritually significant day on Sunday as His Holiness Siri Rajrajeshwar Guruji, head of the International Siddhashram Shakti Centre, London, performed the Dhwaja ritual at the historic Ambaji Temple in Gujarat, one of the most revered Shakti Peeths of India.

Keep ReadingShow less
Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Mahesh Liloriya

The International Siddhashram Shakti Centre in Harrow witnessed an inspiring and environmentally responsible celebration of Ganesh Utsav 2025, which concluded on Saturday, 6 September, with the Ganesh Visarjan ritual performed on the sacred occasion of Anant Chaturdashi.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less